Renato Fanin Selected Research

Renato Fanin Research Topics

Disease

29	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 05/2002
18	Multiple Myeloma 01/2022 - 07/2002
16	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 02/2002
15	Neoplasms (Cancer) 01/2022 - 04/2004
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 11/2002
10	Infections 11/2020 - 10/2004
8	Leukemia 01/2022 - 09/2003
8	Hematologic Neoplasms (Hematological Malignancy) 08/2021 - 09/2003
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2004
7	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 10/2008
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2018 - 01/2002
5	COVID-19 01/2022 - 01/2021
5	Lymphoma (Lymphomas) 12/2020 - 09/2003
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2013 - 11/2003
4	Mycoses (Diseases, Fungus) 12/2021 - 11/2008
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2008
4	Pathologic Complete Response 01/2017 - 10/2005
3	Thrombocytopenia (Thrombopenia) 12/2018 - 02/2002
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 10/2004
3	Residual Neoplasm 12/2017 - 01/2009
3	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 04/2012 - 02/2002
3	Autoimmune Diseases (Autoimmune Disease) 03/2006 - 05/2003
3	Acute Promyelocytic Leukemia 05/2004 - 05/2002
2	Febrile Neutropenia 10/2020 - 08/2005
2	Essential Thrombocythemia 01/2019 - 04/2004
2	Thrombosis (Thrombus) 12/2018 - 05/2016
2	Hemorrhage 12/2018 - 07/2003
2	Invasive Fungal Infections 11/2018 - 09/2005
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017 - 03/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2015 - 01/2007
2	Hodgkin Disease (Hodgkin's Disease) 04/2015 - 04/2002
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2014 - 04/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014 - 05/2003
2	Cardiotoxicity 01/2014 - 06/2008
2	Fever (Fevers) 10/2004 - 05/2003
2	Hemolytic Anemia 11/2003 - 02/2002
2	Immune System Diseases (Immune Disorders) 11/2003 - 02/2002
2	Cryoglobulinemia 05/2003 - 08/2002

Drug/Important Bio-Agent (IBA)

17	Rituximab (Mabthera)FDA Link 01/2020 - 02/2002
11	Imatinib Mesylate (Gleevec)FDA Link 11/2018 - 01/2005
10	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2002
9	Pharmaceutical PreparationsIBA 12/2021 - 11/2002
9	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2002
7	fludarabineIBA 01/2021 - 12/2003
5	Bortezomib (Velcade)FDA Link 01/2022 - 02/2005
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 10/2004
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 03/2013 - 05/2002
5	Dexamethasone (Maxidex)FDA LinkGeneric 03/2013 - 06/2006
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2017
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 01/2002
4	SteroidsIBA 11/2018 - 11/2004
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 10/2005
4	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 10/2005
4	Biological ProductsIBA 04/2017 - 04/2012
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 03/2012
3	Busulfan (Busulfex)FDA Link 01/2021 - 04/2004
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2012
3	Bendamustine Hydrochloride FDA Link 01/2017 - 09/2013
3	AnthracyclinesIBA 01/2014 - 05/2004
3	Thalidomide (Thalomid)FDA Link 12/2011 - 05/2003
3	AutoantibodiesIBA 03/2006 - 02/2002
2	venetoclaxIBA 06/2022 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2014
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 09/2014
2	AzolesIBA 12/2021 - 09/2005
2	AntibodiesIBA 08/2021 - 05/2003
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2021 - 01/2019
2	Thrombopoietin ReceptorsIBA 01/2021 - 05/2016
2	eltrombopag FDA Link 01/2021 - 12/2018
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 06/2013
2	Decitabine FDA Link 01/2021 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 10/2004
2	Meropenem (Merrem)FDA LinkGeneric 10/2020 - 08/2020
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 05/2006
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2007
2	Dasatinib (BMS 354825)FDA Link 11/2019 - 01/2013
2	ruxolitinibIBA 04/2019 - 10/2017
2	SuspensionsIBA 12/2018 - 01/2017
2	Proton Pump InhibitorsIBA 11/2018 - 12/2013
2	posaconazole FDA Link 11/2018 - 12/2013
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 10/2015
2	nilotinib FDA Link 08/2015 - 01/2009
2	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 03/2013 - 05/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2006 - 11/2002
2	Amifostine (Ethyol)FDA LinkGeneric 04/2006 - 04/2004
2	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2006 - 01/2003
2	Infliximab (Remicade)FDA Link 11/2004 - 10/2004
2	Prednisone (Sone)FDA LinkGeneric 10/2004 - 12/2003

Therapy/Procedure

39	Therapeutics 01/2022 - 05/2002
34	Stem Cell Transplantation 01/2021 - 04/2002
19	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
18	Hematopoietic Stem Cell Transplantation 11/2020 - 02/2005
10	Transplantation 01/2022 - 09/2003
8	Salvage Therapy 12/2020 - 03/2012
7	Homologous Transplantation 01/2022 - 06/2006
5	Cell Transplantation 01/2021 - 06/2006
4	Induction Chemotherapy 11/2018 - 11/2008
4	Autologous Transplantation 01/2018 - 09/2003
2	Splenectomy 01/2019 - 05/2016
2	Radiotherapy 04/2015 - 07/2005